Lesions

Lesions are abnormal tissue regions arising from disease, injury, infection, or degeneration, studied in biomedical engineering primarily through medical imaging modalities like CT, MRI, and ultrasound for detection and characterization.

What Are Lesions?

Lesions are abnormal tissue regions within a biological organism, arising from disease, injury, infection, or degeneration, that differ in structure, density, or composition from surrounding healthy tissue. In engineering and biomedical research, lesions are studied primarily through the lens of medical imaging: the goal is to detect, localize, characterize, and track these anomalies using imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, X-ray radiography, and nuclear imaging. Automated lesion analysis is one of the most active areas of applied signal processing and machine learning in medicine, requiring integration of image acquisition physics, anatomy, and pattern recognition.

Lesion analysis draws on electrical engineering, computer science, medical physics, and clinical medicine. Engineering contributions include the development of imaging hardware, signal reconstruction algorithms, and computer-aided detection (CAD) systems that assist radiologists in interpreting large volumes of image data.

Imaging Modalities and Detection

Different lesion types are best visualized with specific modalities depending on their size, composition, and location in the body. Lung nodules, which may indicate early-stage malignancy, are predominantly assessed through CT imaging; automated nodule detection systems analyze three-dimensional CT volumes to flag suspicious regions for radiologist review. Brain lesions associated with multiple sclerosis appear as hyperintense regions on T2-weighted MRI sequences; segmentation algorithms isolate these regions to measure lesion load over time. Liver lesions require multi-phase CT or contrast-enhanced MRI to distinguish between benign cysts, hemangiomas, and primary or metastatic malignancies based on enhancement patterns. A broad review of deep learning approaches to these detection problems, published in PMC by a team reviewing medical imaging progress, surveys the performance of neural networks across CT, MRI, ultrasound, and digital pathology platforms.

Deep Learning and Segmentation

Traditional computer-aided detection systems relied on hand-crafted image features such as intensity statistics, edge gradients, and shape descriptors. Deep convolutional neural networks, particularly encoder-decoder architectures like U-Net, learn feature representations directly from annotated training data and have substantially improved performance across lesion detection and segmentation tasks. Detection networks output bounding boxes around candidate lesion regions, while segmentation networks produce pixel-level masks that quantify lesion volume and boundary. Multi-task learning approaches train a single network to simultaneously classify lesion type and localize it within the image, improving efficiency by exploiting shared intermediate feature representations. The 2017 ISBI skin lesion analysis challenge, hosted by the International Skin Imaging Collaboration, became a widely referenced benchmark for melanoma detection algorithms, attracting 593 registered participants and establishing standardized evaluation protocols that remain in use.

Clinical Translation and Validation

Translating automated lesion detection from research to clinical practice requires regulatory approval, prospective clinical validation, and integration with radiology workflow software such as PACS (picture archiving and communication systems) and electronic health records. Systems must demonstrate performance that generalizes beyond the training data distribution, which in practice means validation on images from different scanner manufacturers, acquisition protocols, and patient populations. The U.S. Food and Drug Administration reviews CAD devices as medical devices under the 510(k) or De Novo pathways, requiring performance data demonstrating safety and effectiveness. Standardized benchmarks and public datasets, including the NIH National Cancer Institute Cancer Imaging Archive, have accelerated algorithm development by providing large collections of expert-annotated lesion data for training and independent testing.

Applications

Lesions, as subjects of biomedical engineering research and clinical practice, have applications in a wide range of fields, including:

  • Early cancer screening and detection in radiology AI systems
  • Radiation therapy planning requiring precise delineation of tumor boundaries
  • Neurological monitoring of multiple sclerosis and stroke lesion progression
  • Dermatology AI tools for melanoma risk stratification
  • Surgical planning using preoperative imaging to map lesion extent
  • Drug development trials measuring lesion response as a quantitative biomarker
Loading…